Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials
Authors
Keywords
-
Journal
CNS SPECTRUMS
Volume 20, Issue 02, Pages 148-156
Publisher
Cambridge University Press (CUP)
Online
2014-06-05
DOI
10.1017/s1092852914000273
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Major Depressive Disorder in the African American Population
- (2015) Rahn K. Bailey et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study
- (2014) David Bakish et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- The Epidemiology of Depression Across Cultures
- (2013) Ronald C. Kessler et al. Annual Review of Public Health
- Treatment response for acute depression is not associated with number of previous episodes: Lack of evidence for a clinical staging model for major depressive disorder
- (2013) Seetal Dodd et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and Safety of Levomilnacipran Sustained Release in Moderate to Severe Major Depressive Disorder
- (2013) Stuart A. Montgomery et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder
- (2013) Gregory M. Asnis et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder
- (2013) Angelo Sambunaris et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety
- (2013) A.L. Auclair et al. NEUROPHARMACOLOGY
- The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder
- (2012) Carol R. Reed et al. CURRENT MEDICAL RESEARCH AND OPINION
- Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED Trial Report
- (2012) S. C. Sung et al. PSYCHOLOGICAL MEDICINE
- Factors Predicting Reduced Antidepressant Response: Experience with the SNRI Duloxetine in Patients with Major Depression
- (2011) Robert H. Howland et al. Annals of Clinical Psychiatry
- Cross-national epidemiology of DSM-IV major depressive episode
- (2011) Evelyn Bromet et al. BMC Medicine
- Efficacy of Antidepressants for Late-Life Depression
- (2011) Enrico Tedeschini et al. JOURNAL OF CLINICAL PSYCHIATRY
- Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report
- (2011) A. J. Rush et al. PSYCHOLOGICAL MEDICINE
- Examining the role of race and ethnicity in relapse rates of major depressive disorder
- (2010) Nhi-Ha T. Trinh et al. COMPREHENSIVE PSYCHIATRY
- Analysis by Age and Sex of Efficacy Data From Placebo-Controlled Trials of Desvenlafaxine in Outpatients With Major Depressive Disorder
- (2010) Susan G. Kornstein et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Duration of untreated illness and antidepressant fluvoxamine response in major depressive disorder
- (2010) Akiko Okuda et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Objective: remission of depression in primary care
- (2009) Marc Ansseau et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?
- (2009) Stuart A. Montgomery et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Health related quality of life in recurrent depression: A comparison with a general population sample
- (2009) Mascha C. ten Doesschate et al. JOURNAL OF AFFECTIVE DISORDERS
- The associations between socio-economic status and major depressive disorder among Blacks, Latinos, Asians and non-Hispanic Whites: findings from the Collaborative Psychiatric Epidemiology Studies
- (2009) A. R. Gavin et al. PSYCHOLOGICAL MEDICINE
- Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence
- (2008) J Craig Nelson et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study
- (2008) Sheila M. Marcus et al. COMPREHENSIVE PSYCHIATRY
- Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD
- (2008) George I. Papakostas et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started